Page 61 - Read Online
P. 61
Chen et al. Contralateral cerebral ischemia after MMD bypass
factors in moyamoya disease. J Neurol Neurosurg Psychiatry Analg 1997;85:1060-5.
2010;81:673-8. 31. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff
29. Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, MA. Long-term outcome in children with moyamoya syndrome
Tominaga T. Minocycline prevents focal neurological deterioration after cranial revascularization by pial synangiosis. J Neurosurg
due to cerebral hyperperfusion after extracranial-intracranial bypass
for moyamoya disease. Neurosurgery 2014;74:163-70. 2004;100:142-9.
30. Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya 32. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya
H, Karasawa J. Risk factors for neurologic deterioration after disease among young patients: its aggressive clinical course and the
revascularization surgery in patients with moyamoya disease. Anesth role of active surgical treatment. Neurosurgery 2004;54:840-4.
Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ March 24, 2017 53
